The present application relates to compounds of formula Iwherein R<;sup>;1<;/sup>;, R<;sup>;2<;/sup>;and R<;sup>;3<;/sup>;are as defined herein and such compounds are for use in a method of treating, preventing or managing cancer. Said cancer can be leukemia. Said method can further comprise administering a second agent. Pharmaceutical compositions and single unit dosage forms comprising such compounds are also provided.